Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease
- DOI
- 10.1080/17512433.2025.2556122
- Published
- 2025-09-22
- Container
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/17512433.2025.2556122,
title = {Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease},
author = {Emily Francis and Samantha Paylor and Cindy Van and Bindu Mathews and Millad J. Sobhanian and Daniel Z. Mansour and George Hennawi and Nicole J. Brandt},
year = {2025},
journal = {Expert Review of Clinical Pharmacology},
doi = {10.1080/17512433.2025.2556122},
url = {https://doi.org/10.1080/17512433.2025.2556122}
}RIS
TY - JOUR TI - Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease AU - Emily Francis AU - Samantha Paylor AU - Cindy Van AU - Bindu Mathews AU - Millad J. Sobhanian AU - Daniel Z. Mansour AU - George Hennawi AU - Nicole J. Brandt PY - 2025 JO - Expert Review of Clinical Pharmacology DO - 10.1080/17512433.2025.2556122 UR - https://doi.org/10.1080/17512433.2025.2556122 ER -
APA
Francis, E., Paylor, S., Van, C., Mathews, B., Sobhanian, M. J., Mansour, D. Z., Hennawi, G., & Brandt, N. J. (2025). Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2556122
Source records
- crossref · retrieved 2026-09-26T15:56:55.114Z